“…Many of the acute and chronic features of clinical fungal asthma are recapitulated in the experimental model that we have developed in our laboratory in which sensitization with fungal extracts is followed by allergy challenge via inhaled Aspergillus (Hoselton et al, 2010; Schuh and Hoselton, 2013; Samarasinghe et al, 2011). We observe IgE production, eosinophilia, leukocyte recruitment, and pronounced peribronchial ECM changes that are exaggerated upon subsequent exposure to inhaled conidia (Ghosh et al, 2012a, 2013, 2014a; Chaudhary and Marr, 2011; Hoselton et al, 2010; Pandey et al, 2013). …”